Subscribe To
genelux corporation reports inducement grants under nasdaq listing rule 5635(c)(4)
WESTLAKE VILLAGE, Calif., Sept. 14, 2023 (GLOBE NEWSWIRE) — genelux Corporation (NASDAQ: GNLX), a lat...
September 14, 2023, 11:00 am
genelux corporation strengthens senior management and clinical team with promotions and new hires
WESTLAKE VILLAGE, Calif., July 20, 2023 (GLOBE NEWSWIRE) — genelux Corporation (NASDAQ: GNLX), a late...
July 20, 2023, 8:45 pm
genelux: a game changer in platinum-resistant ovarian cancer
genelux, an immuno-oncology frontrunner, has secured over $65 million in financing and is conducting su...
July 11, 2023, 4:12 am
genelux corporation announces $18 million private placement
WESTLAKE VILLAGE, Calif., June 12, 2023 (GLOBE NEWSWIRE) — genelux Corporation (NASDAQ: GNLX), a late...
June 12, 2023, 11:00 am
Why shares of genelux corporation jumped this week
genelux focuses on hard-to-treat cancers. Its lead therapy is Olvi-Vec, which did well in a phase 2 tri...
June 1, 2023, 5:19 pm
genelux: recent ipo with phase 3 stage oncolytic virus cancer therapy
GNLX IPO-ed recently, but the company has been around for two decades. The company develops an oncolytic virus targeting cancer....
March 26, 2023, 10:50 pm
: genelux ipo prices at bottom of range
genelux Corp. priced its initial public offering at $6 a share, the low end of its $6 to $7 a share ran...
January 26, 2023, 11:40 am
genelux ipo prices at bottom of range
genelux Corp. priced its initial public offering at $6 a share, the low end of its $6 to $7 a share ran...
January 26, 2023, 6:40 am